Exhibit 99.14

    Avocent Reports Higher Sales and Net Income for Third Quarter

    HUNTSVILLE, Ala.--(BUSINESS WIRE)--Oct. 20, 2005--Avocent
Corporation (NASDAQ:AVCT) today reported higher sales for the third
quarter ended September 30, 2005. Net sales for the third quarter
increased 5.9% to $96.7 million compared with sales of $91.3 million
in the third quarter of 2004.
    "Avocent's sales, gross margin and net income rose in the third
quarter and benefited from increased demand for our digital and
embedded products," stated John R. Cooper, chairman and chief
executive officer of Avocent Corporation. "Digital product sales
accounted for 53.2% of revenues in the third quarter, up from 48.7% in
the third quarter of 2004, on the strength of new products introduced
since last year, including DSView3. We also posted record revenues
from embedded products this quarter as project wins continue to
contribute to revenue growth.
    "Sequentially, we were pleased to experience 8% growth in revenues
from the second quarter of 2005," continued Mr. Cooper. "Branded sales
particularly demonstrated strength, with a sequential increase of
14%."
    Income prior to intangible amortization and merger-related
expenses was $18.0 million, or $0.36 per diluted share, compared with
income prior to intangible amortization and merger-related expenses of
$17.2 million, or $0.34 per diluted share, in the third quarter of
2004. (See "Use of Non-GAAP Financial Measures" discussion below.) Net
adjustments to reconcile to GAAP net income were $1.7 million in the
third quarter of 2005, including $2.7 million in intangible
amortization and a $1.8 million tax benefit. Net adjustments to
reconcile to GAAP net income were $6.4 million in the third quarter of
2004, including $6.5 million in intangible amortization, a $1.1
million charge for acquired in-process research and development
expense related to Sonic Mobility and a $2.8 million tax benefit.
    GAAP net income for the third quarter of 2005 was $16.4 million,
or $0.33 per diluted share. This compares with GAAP net income of
$10.8 million, or $0.21 per diluted share, in the third quarter of
2004.
    Branded sales increased 6.2% from the third quarter of 2004 and
accounted for 54.0% of total sales. OEM sales increased 5.5% from the
third quarter of 2004 and accounted for 46.0% of total third quarter
2005 sales. U.S. sales increased 3.6% to $58.0 million and
international sales rose 9.6% to $38.7 million compared with the third
quarter of 2004.
    "Sales were up in all major geographic regions and were
particularly strong in Asia in the third quarter," continued Mr.
Cooper. "We have increased our sales and marketing staff in Asia
during the past two years. As a result, branded and OEM sales in Asia
were up 21% compared with the third quarter of last year."
    Gross profit for the third quarter of 2005 increased 7.9% to $57.3
million with a gross margin of 59.3%. This compared with gross profit
of $53.1 million and a gross margin of 58.2% in the third quarter of
2004. The increase in gross profit was due to higher sales of digital
products and higher royalty income.
    Research and development expenses increased 24.3% to $14.6
million, or 15.1% of sales, compared with $11.8 million, or 12.9% of
sales, in the third quarter of 2004. This increase was due primarily
to additional engineering teams added from the acquisition of Sonic
Mobility and engineering staff added to support embedded products and
other key development projects.
    Selling, general and administrative expenses declined 2.1% to
$20.8 million compared with $21.2 million in the third quarter of
2004. The decline in SG&A expenses was due primarily to lower legal
fees and lower Sarbanes-Oxley compliance costs, although these savings
were partially offset by increased investments in marketing programs.
    Avocent's balance sheet and cash position remained strong as of
September 30, 2005. The Company's cash flow from operations was
approximately $21 million for the third quarter of 2005 with
approximately $333 million in cash, cash equivalents and investments
at the quarter's end. Avocent had no long-term debt as of September
30, 2005.

    Use of Non-GAAP Financial Measures

    Income prior to intangible amortization and merger-related
expenses, or operational income as used in the attached financial
statement schedules, is not a measure of financial performance under
generally accepted accounting principles (GAAP) and should not be
considered a substitute for or superior to GAAP. Avocent's management
uses operational income as a financial measure to evaluate performance
and allocate resources within the Company. Management believes this
measure presents the Company's results on a more comparable
operational basis by excluding non-cash amortization expenses,
non-operational expenses associated with mergers and acquisitions, and
significant and unusual non-recurring gains and losses on sales or
impairments of investments made by Avocent. Avocent believes that
operational income is a measure of performance used by some investment
banks, analysts, investors and others to make informed investment
decisions. Other companies may calculate operational income in a
different manner so this measure may not be comparable to similar
measures presented by other companies. A reconciliation of Avocent's
results using operational measures and GAAP is set forth in the
condensed consolidated statements of operations included in this press
release.

    Conference Call Information

    Avocent will provide an on-line, real-time Web-cast and
rebroadcast of its third quarter results conference call to be held
October 20, 2005. The live broadcast will be available on-line at
www.avocent.com as well as www.investorcalendar.com beginning at 10:00
a.m. central time. The on-line replay will follow immediately and
continue for 30 days.

    About Avocent Corporation

    Avocent Corporation is the leading supplier of connectivity
solutions for enterprise data centers, service providers and financial
institutions worldwide. Branded products include switching, extension,
intelligent platform management interface (IPMI), remote access and
video display solutions. Additional information is available at:
www.avocent.com.

    Forward-Looking Statements

    This press release contains statements that are forward-looking
statements as defined within the Private Securities Litigation Reform
Act of 1995. These include statements regarding the development,
introduction, features, and benefits of new products and technologies,
the size and growth of the current and future markets for these
products and technologies (including our combined embedded KVM and
IPMI solutions), and engineering and design activities. These
forward-looking statements are subject to risks and uncertainties that
could cause actual results to differ materially from the statements
made, including the risks associated with general economic conditions,
risks attributable to future product demand, sales, and expenses,
risks associated with reliance on a limited number of customers,
component suppliers, and single source components, risks associated
with acquisitions, risks associated with product design efforts and
the introduction of new products and technologies, and risks
associated with obtaining and protecting intellectual property rights.
Other factors that could cause operating and financial results to
differ are described in Avocent's annual report on Form 10-K filed
with the Securities and Exchange Commission on March 14, 2005. Other
risks may be detailed from time to time in reports to be filed with
the SEC. Avocent does not undertake any obligation to publicly update
its forward-looking statements based on events or circumstances after
the date hereof.


                          AVOCENT CORPORATION
            Condensed Consolidated Statements of Operations
           (Unaudited, in thousands, except per share data)

                                           For the Quarter Ended
                                             September 30, 2005
                                      Operational Adjustments   GAAP
                                                      (a)
                                      ----------- ----------- --------

Net sales                                $96,708              $96,708
Cost of sales                             39,388               39,388
                                      ----------- ----------- --------
  Gross profit                            57,320           -   57,320

Research and development expenses         14,350         290   14,640
Selling, general and administrative
 expenses                                 20,394         370   20,764
Amortization of intangible assets              -       2,731    2,731
                                      ----------- ----------- --------
  Operating income                        22,576      (3,391)  19,185

Other income (expense), net                2,082         (15)   2,067
                                      ----------- ----------- --------
Income before income taxes                24,658      (3,406)  21,252

Provision for income taxes                 6,639      (1,752)   4,887
                                      ----------- ----------- --------
Net income                               $18,019     $(1,654) $16,365
                                      =========== =========== ========

Earnings per share:
  Basic                                    $0.37                $0.33
  Diluted                                  $0.36                $0.33

Weighted average shares and common
 equivalents outstanding:
  Basic                                   48,966           -   48,966
  Diluted                                 49,904         (25)  49,879


                                           For the Quarter Ended
                                              October 1, 2004
                                      Operational Adjustments   GAAP
                                                      (a)
                                      ----------- ----------- --------

Net sales                                $91,325              $91,325
Cost of sales                             38,201               38,201
                                      ----------- ----------- --------
  Gross profit                            53,124           -   53,124

Research and development expenses         11,059        $715   11,774
Acquired in-process research and
 development expense                           -       1,050    1,050
Selling, general and administrative
 expenses                                 20,344         863   21,207
Amortization of intangible assets              -       6,482    6,482
                                      ----------- ----------- --------
  Operating income                        21,721      (9,110)  12,611

Other income (expense), net                1,238         (15)   1,223
                                      ----------- ----------- --------
Income before income taxes                22,959      (9,125)  13,834

Provision for income taxes                 5,786      (2,774)   3,012
                                      ----------- ----------- --------
Net income                               $17,173     $(6,351) $10,822
                                      =========== =========== ========

Earnings per share:
  Basic                                    $0.35                $0.22
  Diluted                                  $0.34                $0.21

Weighted average shares and common
 equivalents outstanding:
  Basic                                   49,323           -   49,323
  Diluted                                 50,644        (142)  50,502


(a) Note: Adjustments relate to acquired in-process research and
    development expense from the Sonic Mobility Inc. acquisition and
    amortization of deferred compensation (from the capitalization of
    the value of stock options assumed) and intangibles recorded as
    the result of the merger of Apex and Cybex, the acquisitions of
    Equinox, 2C, Soronti, Crystal Link, OSA and Sonic Mobility. The
    calculation of weighted average shares and common equivalents
    outstanding differs due to excluding the average unamortized
    deferred compensation expense in calculating the operational
    diluted shares outstanding.


                          AVOCENT CORPORATION
            Condensed Consolidated Statements of Operations
           (Unaudited, in thousands, except per share data)

                                        For the Nine Months Ended
                                             September 30, 2005
                                     Operational Adjustments   GAAP
                                                     (b)
                                     ----------- ----------- ---------

Net sales                              $263,051              $263,051
Cost of sales                           109,322               109,322
                                     ----------- ----------- ---------
  Gross profit                          153,729           -   153,729

Research and development expenses        42,624         871    43,495
Selling, general and administrative
 expenses                                65,946       1,123    67,069
Amortization of intangible assets             -      15,976    15,976
                                     ----------- ----------- ---------
  Operating income                       45,159     (17,970)   27,189

Income from settlement of lawsuit         5,000                 5,000
Other income (expense), net               5,991         (45)    5,946
                                     ----------- ----------- ---------
Income before income taxes               56,150     (18,015)   38,135

Provision for income taxes               14,925      (6,087)    8,838
                                     ----------- ----------- ---------
Net income                              $41,225    $(11,928)  $29,297
                                     =========== =========== =========

Earnings per share:
  Basic                                   $0.83                 $0.59
  Diluted                                 $0.82                 $0.58

Weighted average shares and common
 equivalents outstanding:
  Basic                                  49,550           -    49,550
  Diluted                                50,563         (39)   50,524


                                        For the Nine Months Ended
                                              October 1, 2004
                                     Operational Adjustments   GAAP
                                                     (b)
                                     ----------- ----------- ---------

Net sales                              $265,206              $265,206
Cost of sales                           111,190        $190   111,380
                                     ----------- ----------- ---------
  Gross profit                          154,016        (190)  153,826

Research and development expenses        30,650       1,778    32,428
Acquired in-process research and
 development expense                          -      29,260    29,260
Selling, general and administrative
 expenses                                60,788       2,790    63,578
Amortization of intangible assets                    17,656    17,656
                                     ----------- ----------- ---------
  Operating income                       62,578     (51,674)   10,904

Other income (expense), net               3,249         (45)    3,204
                                     ----------- ----------- ---------
Income before income taxes               65,827     (51,719)   14,108

Provision for income taxes               17,179      (9,044)    8,135
                                     ----------- ----------- ---------
Net income                              $48,648    $(42,675)   $5,973
                                     =========== =========== =========

Earnings per share:
  Basic                                   $1.00                 $0.12
  Diluted                                 $0.97                 $0.12

Weighted average shares and common
 equivalents outstanding:
  Basic                                  48,663           -    48,663
  Diluted                                50,353         (70)   50,283


(b) Note: Adjustments relate to acquired in-process research and
    development expense from the OSA Technologies Inc. and Sonic
    Mobility Inc. acquisitions and amortization of deferred
    compensation (from the capitalization of the value of stock
    options assumed) and intangibles recorded as the result of the
    merger of Apex and Cybex, the acquisitions of Equinox, 2C,
    Soronti, Crystal Link, OSA and Sonic Mobility. The calculation of
    weighted average shares and common equivalents outstanding differs
    due to excluding the average unamortized deferred compensation
    expense in calculating the operational diluted shares outstanding.


                          AVOCENT CORPORATION
                 Condensed Consolidated Balance Sheets
                       (Unaudited, in thousands)

                                           September 30, December 31,
                                                2005          2004
                                           ------------- -------------

Cash, cash equivalents
  and short-term investments                   $264,186      $239,799
Accounts receivable, net                         57,890        60,948
Inventories, net                                 21,495        21,232
Other current assets                              8,361         5,923
Deferred income tax                               4,173         6,720
                                           ------------- -------------
  Total current assets                          356,105       334,622

Investments                                      68,403        91,547
Property and equipment, net                      38,367        39,896
Goodwill, net                                   269,992       269,892
Intangible assets, net                           18,290        33,981
Other assets                                        894           843
                                           ------------- -------------
  Total assets                                 $752,051      $770,781
                                           ============= =============


Accounts payable and other accrued expenses     $17,105       $21,368
Income tax payable                               11,697         8,494
Other current liabilities                        22,147        16,767
                                           ------------- -------------
  Total current liabilities                      50,949        46,629

Non-current liabilities                           1,724        10,855

Total stockholders' equity                      699,378       713,297
                                           ------------- -------------
  Total liabilities and stockholders'
   equity                                      $752,051      $770,781
                                           ============= =============

    CONTACT: Avocent Corporation
             Edward H. Blankenship, 256-217-1301